Upside – $CKX +61% ($1B cash equity investment led by Brad Jacobs includes a planned $10.13-per-share pre-closing dividend) – $CECO +45% (Q3 beat, FY27 revenue and EBITDA outlooks topped expectations and the FY26 orders view was raised) – $GFR +38% (agrees to be acquired by Strathcona Resources) – $HRTX +29%, $CRMD +3.5% (CorMedix agrees to …
Read in context ›Zura Bio Stock (ZURA)
Track Zura Bio stock through TheStreet Pro's latest coverage, including articles, Daily Diary mentions, TheStreet Pro portfolio activity, contributor watchlist signals, and Pro price levels.
ZURA
Zura Bio
healthcare
At close
$1.24
â–¼ -2.85 (-69.68%)
Nov 9, 4:00 PM ET
After-hours
$1.18
â–¼ -0.06 (-4.84%)
Nov 9, 7:19 PM ET
Market Cap
$393.97M
P/E Ratio
—
1Y Return
+17.53%
EPS (TTM)
-$1.25
Read the latest TheStreet Pro articles mentioning Zura Bio, including market roundups, portfolio updates, trade ideas, and investing analysis.
Articles
1 articleDaily Diary Mentions
1 mentionAMD Up, NVDA Down: Upside, Downside Movers in the Morning
